Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials

ClinicalLIVEUpdated 18 Nov 2026

New Clinical Trials

Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.

Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.

Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777

Signals

What the register says this week, and why it matters if you sell into it.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
  3. 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
  4. A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

Export the full new clinical trials

777 rows as a .csv. Free. Every field, with its source link.

Country 1
Phase
Study type
192 / 777 trials
PostedSponsorStudyPhaseStatus
18 Nov 2026BrocShot IncUnited StatesA Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or Hormonally Affected SkinNot applicableNot Yet Recruiting18 Nov 2026Coherus Oncology, Inc.United StatesA Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid TumorsPhase 1, Phase 2Recruiting18 Nov 2026Cugene Inc.United StatesA Phase I Dose-Escalation Study of CUG279 in Participants With Select Advanced or Metastatic Solid TumorsPhase 1Recruiting18 Nov 2026Driscoll'sUnited StatesA Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety, and Consumer Appeal in Healthy AdultsNot applicableNot Yet Recruiting18 Nov 2026EpetomeUnited StatesA Clinical Trial to Evaluate the Effects of the Synbiotic Dual Cap® on Gastrointestinal Comfort in Adults Initiating GLP-1 or Dual-Incretin Therapy for Weight Loss.Not applicableNot Yet Recruiting18 Nov 2026Etta VitaUnited StatesA Clinical Trial to Evaluate the Effects of a Supplement on Appetite, Gut Health, and Blood SugarNot applicableCompleted18 Nov 2026Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsUnited StatesAleniglipron Renal Impairment StudyPhase 1Not Yet Recruiting18 Nov 2026Good Kitty CoUnited StatesA Clinical Trial to Evaluate the Effects of a Supplement on Urinary SymptomsNot applicableActive Not Recruiting18 Nov 2026MultiValent Biotherapies, Inc.United StatesA Phase 1 Study of MVB-101 Administered Intraprostatically in Patients With Localized Prostate Cancer Who Are Scheduled for Radical ProstatectomyPhase 1Recruiting18 Nov 2026Novo Nordisk A/SUnited StatesExamination of How the Duration of Fasting and Temporary Stopping of Zenagamtide Dosing Affect the Amount of Food Left in the Stomach in Adults With Overweight or Obesity, With or Without Type 2 DiabetesPhase 1Not Yet Recruiting18 Nov 2026South Rampart Pharma, Inc.United StatesA Study Evaluating the Efficacy and Safety of Novel Non-Opioid SRP-001 in Acute Pain After Molar ExtractionPhase 2Not Yet Recruiting18 Nov 2026The Collagen Co. - GLP-1 UsersUnited StatesA Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Nutritional Adequacy, Body Composition, Skin Health, Satiety, and Overall Wellness in Adults Using GLP-1 or Dual-Incretin Medications for Weight ManagementNot applicableNot Yet Recruiting18 Nov 2026The Collagen Co. - GLP-1 UsersUnited StatesA Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin, Hair, Nail, Gut, and Overall Health OutcomesNot applicableNot Yet Recruiting18 Nov 2026Trevi TherapeuticsUnited StatesA Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy ParticipantsPhase 1Recruiting17 Nov 2026Abiomed Inc.United StatesLeft Ventricular Impella Device Real-World Evaluation in Pediatric PatientsActive Not Recruiting17 Nov 2026Aerin MedicalUnited StatesEvaluating Posterior Nasal Nerve Neurolysis for Migraine ReliefNot applicableCompleted17 Nov 2026Aligos TherapeuticsUnited StatesSafety, Tolerability, and Pharmacokinetics of Supratherapeutic Doses of ALG-000184 (Parts A and B) and the Absorption, Metabolism, Excretion, and Absolute Bioavailability of ALG-001075 Following a Single Oral Dose of [14C]ALG-000184 and a Single Intravenous Dose of [13C7,15N1]ALG-001075 (Part C)Phase 1Not Yet Recruiting17 Nov 2026Ashvattha Therapeutics, Inc.United StatesStudy Evaluating Safety & Tolerability of Migaldendranib in US Healthy VolunteersPhase 1Active Not Recruiting17 Nov 2026AstraZenecaUnited States, Argentina, AustraliaA Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCPhase 2Not Yet Recruiting17 Nov 2026Eli Lilly and CompanyUnited StatesA Study of LY3945262 in Healthy ParticipantsPhase 1Not Yet Recruiting17 Nov 2026Novo Nordisk A/SUnited StatesA Research Study of a New Medicine NNC0662-3168 for Weight Management and Type 2 DiabetesPhase 1, Phase 2Not Yet Recruiting17 Nov 2026Novo Nordisk A/SUnited StatesA Research Study Investigating How a New Medicine NNC0721-5186 Works in Women Living With Overweight or ObesityPhase 1Not Yet Recruiting17 Nov 2026NS Pharma, Inc.United States, Australia, CanadaA Global Phase 2 Extension Study of Brogidirsen in Boys With Duchenne Muscular DystrophyPhase 2Enrolling By Invitation17 Nov 2026nucleusRx IncUnited StatesDevelopment of a Virtual Health Care Platform in Heart Failure Patients Transitioning From Hospital to HomeNot applicableEnrolling By Invitation17 Nov 2026SystImmune Inc.United StatesA Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid TumorsPhase 1Recruiting16 Nov 2026ANI PharmaceuticalsUnited StatesACUTE-GO is a Study Testing the Effectiveness and Safety of Two Doses of Purified Cortrophin Gel in Patients With Acute Gouty Arthritis FlaresPhase 4Recruiting16 Nov 2026Bristol-Myers SquibbUnited States, CanadaA Study of BMS-986548 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesPhase 1, Phase 2Not Yet Recruiting16 Nov 2026DermaSensor, Inc.United StatesSkin Cancer Detection in Primary Care With and Without DermaSensorNot applicableNot Yet Recruiting16 Nov 2026Essilor InternationalUnited StatesEvaluation of the Espansione Equinox System Safety & Effectiveness for the Treatment of Meibomian Gland Dysfunction.Not applicableActive Not Recruiting16 Nov 2026Maxona Pharmaceuticals, Inc.United StatesA Study to Evaluate the Safety and Pain Relief of MAX-001 After Surgical Removal of Wisdom TeethPhase 2Not Yet Recruiting16 Nov 2026RAI Services CompanyUnited StatesVuse Pro Puffing Topography Study in Adult SmokersNot applicableRecruiting16 Nov 2026Telios Pharma, Inc.United StatesTL-925 for the Treatment of Allergic ConjunctivitisPhase 2Not Yet Recruiting13 Nov 2026AbbVieUnited StatesA Study to Assess the Adverse Events and How Oral ABBV-1606 Moves Through the Body of Healthy Adult Participants.Phase 1Not Yet Recruiting13 Nov 2026Aclaris Therapeutics, Inc.United StatesStudy of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical TherapiesPhase 2Recruiting13 Nov 2026Eli Lilly and CompanyUnited States, SingaporeA Study Assessing Eloralintide (LY3841136) in Healthy ParticipantsPhase 1Not Yet Recruiting13 Nov 2026Eli Lilly and CompanyUnited StatesA Study of Tersolisib (LY4064809) and Abemaciclib With Hormone Therapies in Participants With PIK3CA-Mutated Early Breast CancerPhase 2Not Yet Recruiting13 Nov 2026Hemab ApSUnited StatesA Phase 3 Evaluation of Sutacimig in Glanzmann ThrombastheniaPhase 3Recruiting13 Nov 2026LembasUnited StatesEffects of a Gut-Active Peptide That Stimulates GLP-1 Release on Appetite and Satiety in Healthy Adults With OverweightNot applicableNot Yet Recruiting12 Nov 2026Aponia Laboratories, Inc.United States, GermanyEffect of S-Ibuprofen Gel on Pain in Acute Soft Tissue ContusionsPhase 3Recruiting12 Nov 2026Colgate PalmoliveUnited StatesClinical Evaluation of an Oil-Balancing Facial Sunscreen With Topical TretinoinPhase 4Enrolling By Invitation12 Nov 2026ENTire Medical Ltd.United StatesPediatric Adeno-Tonsillar Hypertrophy Treatment Post-Approval StudyNot applicableNot Yet Recruiting12 Nov 2026Gedeon Richter Plc.United StatesSafety, Tolerability and Efficacy of RGH-202 in Social Anxiety Disorder (STAGE)Phase 2Not Yet Recruiting12 Nov 2026IMMUNOe Research CentersUnited StatesExploring the Extended Efficacy and Initial Use of RUCONEST® in Managing Neurological Symptoms Linked to Infectious PathogensPhase 4Recruiting12 Nov 2026Neurocrine BiosciencesUnited StatesStudy of NBIB-223 Gene Therapy in Friedreich's Ataxia (FACET)Phase 1Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, BrazilA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, China, JapanA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and ExercisePhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Brazil, ChinaA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting12 Nov 2026Olly, PBCUnited StatesThe Pediatric Sleep StudyNot applicableNot Yet Recruiting12 Nov 2026Oruka Therapeutics, Inc.United States, CanadaAn Open-label Study With Maintenance Dosing of ORKA-002 in Participants With Moderate-to-Severe Plaque PsoriasisPhase 2Enrolling By Invitation

// How AOS uses this

Every row here is a potential account. AOS finds the ones that need what you sell, maps the decision makers and prepares the outreach for your approval.